共 25 条
[2]
Double-blind, randomized trial of an Anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction - Limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study
[J].
CIRCULATION,
2001, 104 (23)
:2778-2783
[6]
de Gaetano G, 1999, HAEMOSTASIS, V29, P41

